| ||
| First-Ever Covalent Irreversible Inhibition Of A Protease Central To Hepatitis ... RedOrbit Avila Therapeutics™, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology ... See all stories on this topic » | ||
| Joule appoints d'Esparbes, Madden to senior roles Mass High Tech ... Joule Unlimited Inc. has appointed Eric d'Esparbes as chief financial officer and Kevin Madden as vice president of biology operations at the firm. ... See all stories on this topic » | ||
| Time For Lyme researcher Karen Newell published Stamford Plus Magazine By Time for Lyme Work supported by a grant from Greenwich based Time for Lyme appears in the Journal of Leukocyte Biology in the October issue. ... See all stories on this topic » | ||
| New Mechanism Controls Blood Sugar Level RedOrbit The breakthrough was made in the University of Leicester by a team led by Professor Andrew Tobin, Professor of Cell Biology, who is a Wellcome Trust Senior ... See all stories on this topic » |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment